2-(3-Bromophenyl)-5-((2,6-dimethylmorpholino)methyl)benzo[d]oxazole

Catalog No. :
ACPCYD439
CAS No. :
1706454-45-6
Molecular Formula :
C20H21BrN2O2
Molecular Weight :
401.30

IUPAC Name:2-(3-bromophenyl)-5-((2,6-dimethylmorpholino)methyl)benzo[d]oxazole

2-(3-Bromophenyl)-5-((2,6-dimethylmorpholino)methyl)benzo[d]oxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$614.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Bromophenyl)-5-((2,6-dimethylmorpholino)methyl)benzo[d]oxazole
IUPAC Name2-(3-bromophenyl)-5-((2,6-dimethylmorpholino)methyl)benzo[d]oxazole
Molecular FormulaC20H21BrN2O2
Molecular Weight401.30
SMILESCC1OC(C)CN(CC2=CC=C(OC(C3=CC=CC(Br)=C3)=N4)C4=C2)C1
InChI KeyRVQGUQMHWMEQJX-UHFFFAOYSA-N
Synonym2-(3-Bromo-phenyl)-5-(2,6-dimethyl-morpholin-4-ylmethyl)-benzooxazole;Benzoxazole, 2-(3-bromophenyl)-5-[(2,6-dimethyl-4-morpholinyl)methyl]-
CAS No.1706454-45-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPCYD439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTPO970 route compound structure diagram
    ACBTPO97080567-00-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPCYD439 route product structure diagram
    ACPCYD4391706454-45-6
Inquiry

2. ACPCYD439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTPO970 route compound structure diagram
    ACBTPO97080567-00-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPCYD439 route product structure diagram
    ACPCYD4391706454-45-6
Inquiry

Comments (0)